Production (Stage)
Fideicomiso Irrevocable F/2061 Fhipo
BNZIF
$0.4683
-$0.0828-15.02%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 6.78M | 21.59M | 9.90M | 10.14M | 8.55M |
| Total Revenue | 6.78M | 21.59M | 9.90M | 10.14M | 8.55M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 6.78M | 21.59M | 9.90M | 10.14M | 8.55M |
| SG&A Expenses | 4.97M | 5.47M | 6.46M | 6.59M | 5.53M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -2.92M | 14.33M | -5.80M | -4.93M | -5.48M |
| Total Operating Expenses | 2.05M | 19.79M | 663.50K | 1.66M | 50.30K |
| Operating Income | 4.73M | 1.80M | 9.24M | 8.48M | 8.50M |
| Income Before Tax | 4.73M | 2.42M | 9.24M | 8.48M | 8.50M |
| Income Tax Expenses | 16.90K | -190.20K | 45.00K | 78.70K | 82.70K |
| Earnings from Continuing Operations | 4.71M | 2.61M | 9.19M | 8.41M | 8.42M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.71M | 2.61M | 9.19M | 8.41M | 8.42M |
| EBIT | -- | -- | -- | -- | -- |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.02 | 0.02 | 0.04 | 0.04 | 0.04 |
| Normalized Basic EPS | 0.01 | 0.01 | 0.03 | 0.02 | 0.02 |
| EPS Diluted | 0.02 | 0.02 | 0.04 | 0.04 | 0.04 |
| Normalized Diluted EPS | 0.01 | 0.01 | 0.03 | 0.02 | 0.02 |
| Average Basic Shares Outstanding | 227.19M | 143.20M | 227.19M | 229.97M | 232.75M |
| Average Diluted Shares Outstanding | 227.19M | 143.20M | 227.19M | 229.97M | 232.75M |
| Dividend Per Share | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 |
| Payout Ratio | 51.64% | 315.68% | 79.16% | 93.72% | 132.83% |